Joel Lexchin's guest appearances

Joel Lexchin

Causes or Cures

Moment of Truth

Dave Smith

Greg Miller

John Kelly

Richard Bell

James Wilson

Samantha Brown

Nicole LePera

Bill Gurley

Jim Davies

Kent Monkman

Kenneth Williams

Evan Thompson

Maura Judkis

David Robertson

Steven Hyman

OwlTail

Lisa Parker

Continuing the exploration of industry's influence on healthcare and health policy, in this episode of Causes or Cures, Dr. Eeks chats with Dr. Joel Lexchin and Dr. Lisa Parker about the influence drug companies have over patient groups. They will describe what patient groups are (why they are needed &amp; the variety of work they do), why drug companies have a vested interest in patient groups, how drug companies fund and influence the groups (and sometimes even create them) and how the groups influence healthcare policy. They will also discuss practical things that can be done to make the overall health system put patients over profit.  Dr. Lexchin is a professor at York University, where he teaches pharmaceutical policy, an emergency medicine physician, a fellow of the Canadian Academy of Health Sciences, a member of the Ontario Drug Quality and Therapeutics Committee and was chair of the Drugs and Pharmacotherapy Committee of the Ontario Medical Association. Dr. Parker is an honorary senior lecturer at the School of Pharmacy at the University of Sydney and on the faculty of medicine and health. She is a clinician who practices in the field of oncology(cancer) and her research focuses on public health ethics and policy.You can contact Dr. Eeks at bloomingwellness.com.Follow Dr. Eeks on Instagram here.Or Facebook here.Or Twitter.Subcribe to her newsletter here!Support the show

Continuing the exploration of industry's influence on healthcare and health policy, in this episode of Causes or Cures, Dr. Eeks chats with Dr. Joel Lexchin and Dr. Lisa Parker about the influence drug companies have over patient groups. They will describe what patient groups are (why they are needed &amp; the variety of work they do), why drug companies have a vested interest in patient groups, how drug companies fund and influence the groups (and sometimes even create them) and how the groups influence healthcare policy. They will also discuss practical things that can be done to make the overall health system put patients over profit. Dr. Lexchin is a professor at York University, where he teaches pharmaceutical policy, an emergency medicine physician, a fellow of the Canadian Academy of Health Sciences, a member of the Ontario Drug Quality and Therapeutics Committee and was chair of the Drugs and Pharmacotherapy Committee of the Ontario Medical Association. Dr. Parker is an honorary senior lecturer at the School of Pharmacy at the University of Sydney and on the faculty of medicine and health. She is a clinician who practices in the field of oncology(cancer) and her research focuses on public health ethics and policy. You can contact Dr. Eeks at <a href="http://www.bloomingwellness.com/" rel="nofollow" target="_blank">bloomingwellness.com.</a> Follow Dr. Eeks on <a href="https://www.instagram.com/doctoreeks/" rel="nofollow" target="_blank">Instagram</a> here. Or <a href="https://www.facebook.com/DoctorEeKs" rel="nofollow" target="_blank">Facebook</a> here. Or <a href="https://twitter.com/dr_eeks" rel="nofollow" target="_blank">Twitter</a>. Subcribe to her <a href="https://visitor.r20.constantcontact.com/manage/optin?v=001g00wgP1zErs8eONOWuWhBM1AyRPzLjHX_oT2Pqxub8anrwsCVf5945QIdQgWqDnL_xCoekQ4SYoNyh0d7qbtKFLXWzTjmn1TaF3K7gfrTSLryYwrmJGh75X7MjPVhHhIx0YNx5QWx39YDro3KE_SiNC2ErM5GL-Z" rel="nofollow" target="_blank">newsletter here!</a> <a href="https://paypal.me/BloomingWellness?country.x=US&amp;locale.x=en_US" rel="payment nofollow" target="_blank">Support the show</a>

How Drug Companies Influence Patient Groups & Why That Matters, with Dr. Lisa Parker & Dr. Joel Lexchin

In this episode of Causes or Cures, Dr. Eeks chats with Dr. Joel Lexchin about his recent research published in the Journal of General Internal Medicine titled: A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough. He will discuss what the Sunshine Act was designed to accomplish in terms of being transparent about physician-industry relationships, what it actually did, and how it did or did not change physician behavior, industry behavior and consumer behavior. Dr. Lexchin is a professor at the York University Faculty of Health where he taught pharmaceutical policy, an emergency medicine physician, and an Associate Professor in the Department of Family and Community Medicine at the University of Toronto. He is a Fellow in the Canadian Academy of Health Sciences and the author of over 160 peer-reviewed publications. He was a member of the Ontario Drug Quality and Therapeutics Committee and chair of the Drugs and Pharmacotherapy Committee of the Ontario Medical Association for 2 years.You can contact Dr. Eeks at bloomingwellness.com.Follow Dr. Eeks on Instagram here.Or Facebook here.Or Twitter.Subcribe to her newsletter here!Support the show

In this episode of Causes or Cures, Dr. Eeks chats with Dr. Joel Lexchin about his recent <a href="https://pubmed.ncbi.nlm.nih.gov/33694070/" rel="nofollow" target="_blank">research </a>published in the Journal of General Internal Medicine titled: A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough. He will discuss what the Sunshine Act was designed to accomplish in terms of being transparent about physician-industry relationships, what it actually did, and how it did or did not change physician behavior, industry behavior and consumer behavior.  Dr. Lexchin is a professor at the York University Faculty of Health where he taught pharmaceutical policy, an emergency medicine physician, and an Associate Professor in the Department of Family and Community Medicine at the University of Toronto. He is a Fellow in the Canadian Academy of Health Sciences and the author of over 160 peer-reviewed publications. He was a member of the Ontario Drug Quality and Therapeutics Committee and chair of the Drugs and Pharmacotherapy Committee of the Ontario Medical Association for 2 years. You can contact Dr. Eeks at <a href="http://www.bloomingwellness.com/" rel="nofollow" target="_blank">bloomingwellness.com.</a> Follow Dr. Eeks on <a href="https://www.instagram.com/doctoreeks/" rel="nofollow" target="_blank">Instagram</a> here. Or <a href="https://www.facebook.com/DoctorEeKs" rel="nofollow" target="_blank">Facebook</a> here. Or <a href="https://twitter.com/dr_eeks" rel="nofollow" target="_blank">Twitter</a>. Subcribe to her <a href="https://visitor.r20.constantcontact.com/manage/optin?v=001g00wgP1zErs8eONOWuWhBM1AyRPzLjHX_oT2Pqxub8anrwsCVf5945QIdQgWqDnL_xCoekQ4SYoNyh0d7qbtKFLXWzTjmn1TaF3K7gfrTSLryYwrmJGh75X7MjPVhHhIx0YNx5QWx39YDro3KE_SiNC2ErM5GL-Z" rel="nofollow" target="_blank">newsletter here!</a><a href="https://paypal.me/BloomingWellness?country.x=US&amp;locale.x=en_US" rel="payment nofollow" target="_blank">Support the show</a>

Relationships Between Doctors & Industry and Why Transparency is Not Enough, with Dr. Joel Lexchin

After Covid-19's tragic toll, Canada must improve the quality of life in long-term care homes. ROBERT JAMES &amp; JOEL LEXCHIN join us with that story. Then, JASMIN ZINE unmasks the racial politics of the coronavirus pandemic.

MOT - Joel Lexchin, Robert James & Jasmin Zine (July 2nd, 2020)